Search Results
The default setting for search results displays All Content. If you prefer to see recent content only, please adjust the date filter.
Filter your results:
Types
Topics
22 Results Found
FDA announces new program to boost domestic drug manufacturing
The Food and Drug Administration Aug. 7 announced a new program to help improve the domestic pharmaceutical supply chain by increasing regulatory predictability and facilitating the construction of drug manufacturing facilities in the U.S.
AHA participates in roundtable with CMS administrator at AtlantiCare in NJ
Centers for Medicare & Medicaid Services Administrator Mehmet Oz, M.D., July 19 visited AtlantiCare health system in New Jersey, making stops at its medical facilities, regional educational institutions and community outreach sites
Litigation: AHA, Hospitals Sue to Require HHS to Meet Deadlines for Deciding Appeals
Appeals court sends order to eliminate backlog of Medicare appeals back to trial court (August 11, 2017)
AHA Response to OMB Deregulation RFI
AHA responds to the Office of Management and Budget Deregulation Request for Information.
AHA Provides Input to Administration on Efforts to Provide Regulatory Relief for Hospitals and Health Systems
The Department of Health and Human Services (HHS) May 13 announced a 60-day public comment period for stakeholders regarding its RFI to remove outdated or unnecessary regulations.
AHA Comments on FTC Anticompetitive Deregulations RFI
The AHA provides an overview of the key statutes and regulations that have impeded competition in the health care market and offer a series of recommendations to remedy these obstacles.
AHA Comments on DOJ Anticompetitive Deregulations RFI
The AHA provides an overview of the key statutes and regulations that have impeded competition in the health care market and offer a series of recommendations to remedy these obstacles.
AHA responds to DOJ, FTC anticompetitive regulation RFIs
AHA May 23 submitted recommendations to the Department of Justice and Federal Trade Commission in response to the agencies’ requests for information on unnecessary or burdensome anticompetitive regulations.
AHA makes 100 suggestions to Trump administration on providing regulatory relief
The AHA May 12 responded to the Office of Management and Budget's April 11 request for information on regulatory relief, making 100 suggestions to the Trump administration to help reduce burden on hospitals and health systems.
Executive order promotes domestic production of medicines, other executive actions
The Trump administration May 5 issued two executive orders on pharmaceutical manufacturing and life-sciences research.